Section Arrow
ORGO.NASDAQ
- Organogenesis Holdings
Quotes are at least 15-min delayed:2025/02/23 06:28 EST
Last
 3.21
-0.17 (-5.03%)
Day High 
3.47 
Prev. Close
3.38 
1-M High
3.85 
Volume 
266.63K 
Bid
3.16
Ask
3.55
Day Low
3.2 
Open
3.46 
1-M Low
3.35 
Market Cap 
424.95M 
Currency USD 
P/E 60.5 
%Yield -- 
10-SMA 3.58 
20-SMA 3.6 
50-SMA 3.41 
52-W High 4.57 
52-W Low 2.165 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.05/0.22
Enterprise Value
524.59M
Balance Sheet
Book Value Per Share
2.22
Cash Flow
Cash Flow Yield
0.03
Income Statement
Total Revenue
433.14M
Operating Revenue Per Share
3.64
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
UPCUniverse Pharmaceuticals Inc0.2003+0.0578+40.56%-- 
TLRYTilray Brands0.9452+0.0775+8.93%-- 
CGCCanopy Growth Corp1.615+0.005+0.31%-- 
TXMDTherapeuticsMD1.291+0.281+27.82%0.39PE
TEVATeva Pharmaceutical Industries Limited16.74-0.26-1.53%-- 
Quotes are at least 15-min delayed:2025/02/23 06:28 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced wound care, surgical and sports medicine markets. Its product category includes Advanced Wound Care and Surgical and Sports Medicine. It has single operating segment which has regenerative medicine. The company generates maximum revenue from Advanced Wound Care products. Some of its products include PuraPly Antimicrobial, Affinity, NuShield, Apligraf, Dermagraft and others.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.